Fairmount Funds Management LLC - Insider Non-Derivative Transactions at Dianthus Therapeutics, Inc. /DE/ (DNTH) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 22, 2024, Fairmount Funds Management LLC's relationship to Dianthus Therapeutics, Inc. /DE/ (DNTH) is Director,TenPercentOwner, and currently has 2,762,837 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other DNTH insiders.
Data Source: SEC.
Fairmount Funds Management LLC - Insider Non-Derivative Transactions of DNTH Common Stock
Fairmount Funds Management LLC - Insider Non-Derivative Transactions at DNTH
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 23, 2024 | Acquisition -- (Common Stock) | 834334 | 12 | 2762837 |
| Sep 20, 2023 | P -- (Common Stock) | 30000 | 13.2 | 1873833 |
| Sep 14, 2023 | P -- (Common Stock) | 9367 | 11.76 | 1843833 |
| Sep 13, 2023 | P -- (Common Stock) | 14887 | 10.85 | 1834466 |